We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 27, 2021

Avelumab and Stereotactic Radiotherapy in Metastatic Castration-Resistant Prostate Cancer

European Urology


Additional Info

European Urology
Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial
Eur Urol 2021 Sep 04;[EPub Ahead of Print], EM Kwan, L Spain, A Anton, CL Gan, L Garrett, D Chang, E Liow, C Bennett, T Zheng, J Yu, C Dai, P Du, S Jia, H Fettke, C Abou-Seif, G Kothari, M Shaw, P Parente, C Pezaro, B Tran, S Siva, AA Azad

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.